Cattedra di Medicina di Genere, Dipartimento di Medicina Molecolare Università di Padova, Direttore UOC di Medicina Generale, Azienda Ospedaliera di Padova
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-12-18 17:19:272022-08-25 16:42:31Dalla medicina di genere alla medicina genere-specifica
Autore: Egija Zaura,Bernd W. Brandt,M. Joost Teixeira de Mattos,Mark J. Buijs,Martien P. M. Caspers,Mamun-Ur Rashid,Andrej Weintraub,Carl Erik Nord,Ann Savell,Yanmin Hu,Antony R. Coates,Mike Hubank,David A. Spratt,Michael Wilson,Bart J. F. Keijser,Wim Crielaard
Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-12-18 16:51:122022-08-25 16:41:02Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces
Autore: Francesco Libero Giorgino Presidente A.G.E.O., Presidente F.I.O.G
La nuove prospettive della Medicina di Genere in Ginecologia.
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-11-12 16:41:532022-08-25 16:40:02La nuove prospettive della Medicina di Genere in Ginecologia.
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-11-12 15:03:402022-08-25 16:39:02Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-11-12 14:54:562022-08-25 16:36:23Gastrointestinal symptoms before and during menses in healthy women
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-11-12 14:47:122022-07-01 12:23:27Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in conjunction with use of a vaginal tampon containing LN® probiotic mixture (L. gasseri LN40, L. fermentum LN99, L. casei subsp. rhamnosus LN113) in the treatment of vaginosis
Autore: F. Anglana, C. Oliva, G. Morgante, F. Pagano
Pelvic InflammatoryDiseaseandSexually Transmitted Diseases,A.C.O.San Filippo Neri, Rome. Division ofObstetricsandGynecologyA.C.O.San Filippo Neri–Rome. Departmentof Pediatrics,Obstetricsand Reproductive MedicineObstetrical and GynecologicalClinic of theUniversityof Studies ofSiena. Department of Experimental Medicine,Second University of Naples
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-11-12 13:54:272022-08-25 16:34:08Prevention of fungal vaginitis / bacterial vaginosis comparing two new devices: tampons releasing a LN® probiotic mix and tampons releasing chlorhexidine vs. neutral tampons (placebo). Open preliminary randomized prospective clinical trial
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-10-27 15:04:332022-05-31 17:04:56SALUTE DELLA DONNA
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png9495julia_lhttps://www.farmagens.it/wp-content/uploads/2022/04/logo.jpgjulia_l2015-10-20 13:46:282022-05-24 17:04:41Ecco come lo sport ci difende dai tumori